SANDRI, Gilda
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 19.130
NA - Nord America 11.230
AS - Asia 6.254
SA - Sud America 893
Continente sconosciuto - Info sul continente non disponibili 206
AF - Africa 183
OC - Oceania 55
Totale 37.951
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 14.849
US - Stati Uniti d'America 10.856
SG - Singapore 1.785
CN - Cina 1.667
GB - Regno Unito 1.350
BR - Brasile 663
HK - Hong Kong 657
VN - Vietnam 622
NL - Olanda 564
DE - Germania 397
BD - Bangladesh 385
SE - Svezia 365
FR - Francia 338
FI - Finlandia 270
KR - Corea 237
RU - Federazione Russa 209
CA - Canada 206
TR - Turchia 186
UA - Ucraina 182
IN - India 145
ID - Indonesia 129
AR - Argentina 86
CH - Svizzera 86
MX - Messico 84
ES - Italia 81
JP - Giappone 81
IE - Irlanda 67
BG - Bulgaria 62
PL - Polonia 58
IQ - Iraq 53
ZA - Sudafrica 51
AU - Australia 48
AT - Austria 44
PK - Pakistan 37
MA - Marocco 34
BE - Belgio 33
MY - Malesia 33
CO - Colombia 32
PH - Filippine 27
AE - Emirati Arabi Uniti 25
VE - Venezuela 25
EG - Egitto 23
NO - Norvegia 23
CZ - Repubblica Ceca 22
EC - Ecuador 22
TW - Taiwan 22
CL - Cile 21
IR - Iran 21
RO - Romania 20
PE - Perù 19
SA - Arabia Saudita 19
CR - Costa Rica 15
GR - Grecia 15
KE - Kenya 15
LT - Lituania 14
AL - Albania 13
MT - Malta 13
NP - Nepal 12
TH - Thailandia 12
IL - Israele 11
PY - Paraguay 11
DZ - Algeria 10
KZ - Kazakistan 10
UZ - Uzbekistan 10
BH - Bahrain 9
BO - Bolivia 9
PT - Portogallo 9
TN - Tunisia 9
AZ - Azerbaigian 7
BZ - Belize 7
DO - Repubblica Dominicana 7
ET - Etiopia 7
GT - Guatemala 7
HU - Ungheria 7
NZ - Nuova Zelanda 7
OM - Oman 7
BB - Barbados 6
HN - Honduras 6
JM - Giamaica 6
JO - Giordania 6
LV - Lettonia 6
NI - Nicaragua 6
SV - El Salvador 6
BY - Bielorussia 5
KG - Kirghizistan 5
MK - Macedonia 5
PA - Panama 5
RS - Serbia 5
SN - Senegal 5
TT - Trinidad e Tobago 5
NG - Nigeria 4
QA - Qatar 4
SI - Slovenia 4
SY - Repubblica araba siriana 4
AM - Armenia 3
CI - Costa d'Avorio 3
GE - Georgia 3
KH - Cambogia 3
LB - Libano 3
MD - Moldavia 3
Totale 37.685
Salva come PNG Salva come JPEG
Città #
Ashburn 1.392
Rome 1.296
Santa Clara 1.274
Milan 1.208
Singapore 1.119
San Jose 1.023
Southend 872
Hefei 655
Hong Kong 644
Naples 496
Fairfield 428
Chandler 408
Council Bluffs 406
Bologna 366
Florence 336
Turin 313
Woodbridge 260
Houston 256
Jacksonville 255
London 250
Los Angeles 247
Seoul 224
Bari 222
Beijing 216
Ho Chi Minh City 209
Nyköping 199
Dearborn 197
Helsinki 189
Chicago 181
Ann Arbor 180
New York 180
Wilmington 173
Modena 168
Seattle 158
The Dalles 158
Catania 153
Parma 150
Genoa 148
Palermo 148
Hanoi 139
São Paulo 113
Verona 113
Cambridge 112
Buffalo 99
Brescia 94
Izmir 92
Jakarta 92
Lauterbourg 89
Dallas 83
Moscow 83
Padova 83
Cagliari 82
Reggio Emilia 77
Pescara 76
Shanghai 74
Munich 71
Princeton 67
San Diego 63
Orem 62
Toronto 61
Salt Lake City 60
Trieste 59
Livorno 57
Sofia 57
Tokyo 56
Boardman 54
Columbus 53
Rimini 52
Vicenza 52
Trento 51
Mexico City 48
Frankfurt am Main 47
Eugene 44
Perugia 43
Tampa 41
Des Moines 38
Venice 38
Elk Grove Village 37
Ancona 35
Bremen 35
Kent 35
Da Nang 34
Monza 34
Phoenix 34
Taranto 33
Treviso 33
Amsterdam 32
Dublin 32
Redwood City 32
Salerno 32
Messina 31
Montreal 31
Ottawa 31
Atlanta 30
Paris 30
Lucca 29
Warsaw 29
Bergamo 28
Denver 28
Falkenstein 28
Totale 20.165
Salva come PNG Salva come JPEG
Nome #
Farmaci biologici e rischio oncologico 4.881
Tempi di sospensione dei farmaci biologici nello switch terapeutico e nella programmazione degli interventi chirurgici 4.832
L’infezione da papilloma virus umano (HPV) nei pazienti con artrite reumatoide trattati con farmaci biologici 3.966
Farmaci biologici e infezione tubercolare 598
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 487
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 422
Farmaci biologici e tematiche relative alla cardiopatia ischemica e all’insufficienza cardiaca 387
Biological Therapy and Risk of Malignancies: A Literature Review 371
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 366
Cryoglobulin evaluation: analysis of intra-laboratory and inter-laboratory variability 362
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 361
Frequency and Results of Cryoglobulin Retesting in 4,963 Patients: Comment on the Article by Kolopp-Sarda et al 348
La legislazione del dolore e la sua applicazione in Italia: pregi e difetti 334
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 331
The discrepancy between clinical and ultrasonographic remission in rheumatoid arthritis is not related to therapy or autoantibody status. 324
HCV associated cryoglobulinemic vasculitis 319
Non HCV-related mixed cryoglobulinemia 319
Early Occupational Therapy Intervention: Patients’ Occupational Needs 318
Large Vessel Vasculitis Occurring in Rheumatoid Arthritis Patient under Anti-TNF Therapy 308
ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA): THE RELATIONSHIP BETWEEN SEX, AGE AND ANTIGENIC SPECIFICITIES 305
Le crioglobuline miste: epidemiologia, clinica ed eziopatogenesi. Contributo personale. 300
ANTI - TUMOR NECROSIS FACTOR ALPHA (ANTI-TNF) DRUGS IN RHEUMATOID ARTHRITIS: COMPARISON ON DISEASE MANAGEMENT BEFORE AND AFTER THE INTRODUCTION OF THESE BIOLOGICAL DRUGS IN MODENA, ITALY 294
EULAR guidelines on ANCA-associated vasculitis in the real life 288
COMPLEMENT DEPLETION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOCILIZUMAB: A MARKER OF CLINICAL EFFICACY? 287
Beyond cat scratch disease: a case report of bartonella infection mimicking vasculitic disorder 281
Ultrasonography in the diagnosis and management of patients with inflammatory arthritides 276
Photobiomodulation Therapy: A New Light in the Treatment of Systemic Sclerosis Skin Ulcers 272
RETENTION RATE OF ADALIMUMAB AND ABP 501 IN THE TREATMENT OF A LARGE COHORT OF PATIENTS WITH INFLAMMATORY ARTHRITIS: A REAL LIFE RETROSPECTIVE ANALYSIS 268
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 267
Adalimumab and ABP 501 in the Treatment of a Large Cohort of Patients with Inflammatory Arthritis: A Real Life Retrospective Analysis 265
Immunodeficiency and autoimmune phenomena in female hyper-IgM syndrome 261
The prevalence of asymptomatic early sacroiliitis in Crohn’s disease patients: The single experience of an Italian tertiary care centre 261
Assessing hand grasp in patients with systemic sclerosis using the 16-grasp test: Preliminary results from a multidisciplinary study group 260
Risankizumab e Upadacitinib nel Trattamento dell'Artrite Psoriasica: Meccanismi Diversi, Obiettivo Comune 259
L’uso dei farmaci biologici durante la gravidanza e l’allattamento 258
EXPERIMENTAL USE OF 3D PRINTING TECHNOLOGY FOR THE CONSTRUCTION OF DEVICES AS INTEGRATION OF OCCUPATIONAL THERAPY INTERVENTION WITH RHEUMATOID ARTHRITIS PATIENTS (RA) 258
Indicazioni chirurgiche alla artrodesi totale di polso nei pazienti affetti da artrite reumatoide. 255
Sanitary costs of osteoarthritis 253
Non-Hodgkin Lymphoma in Psoriatic Arthritis Treated with Sequential, Multiple Anti-TNF-α Agents: A Case Report 250
Epstein-barr virus reactivation after infliximab in rheumatoid arthritis: a case report. 249
Salivary 1H-NMR Metabolomics in Primary Sjögren Syndrome. Preliminary Results of a Pilot Case-Control Study 247
Metabolic Profile of Whole Unstimulated Saliva in Patients with Sjögren's Syndrome 243
Apremilast retention rate in clinical practice: observations from an Italian multi-center study 242
PREVALENCE OF ULTRASOUND ABNORMALITIES IN PATIENTS WITH PSORIATIC ARTHRITIS IN A CLINICAL PHASE OF MINIMAL DISEASE ACTIVITY UNDER ANTI-TNF TREATMENT 236
Predictors of DAPSA Response in Psoriatic Arthritis Patients Treated with Apremilast in a Retrospective Observational Multi-Centric Study (2023-02-07) 235
Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients 235
NATURAL HISTORY OF CRYOGLOBULINEMIA FROM 2000 TO 2018 FROM THE LABORATORY POINT OF VIEW: AN ANALYSIS OF CRYOGLOBULIN CHARACTERISTICS IN A SINGLE CENTER. 233
Baseline Ultrasound Assessment Improves the Response to Apremilast in Patients with Psoriatic Arthritis: Results from a Multicentre Study 230
Farmaci biologici ed epatiti da virus B e C 230
Promising use of filgotinib in patients affected by systemic sclerosis: Preliminary data from a case series of 5 patients 228
Efficacia e sicurezza delle vaccinazioni anti-influenza e anti-pneumococco nei pazienti con artrite reumatoide trattati con farmaci biologici 225
UTILITY OF A SELF ADMINISTERED QUESTIONNAIRE AS A TOOL FOR SCREENING JOINT INVOLVEMENT UNDERWAY PSORIASIS 221
On- and off-label use of rituximab in rheumatic diseases 220
The predictive role of the TAPSE/sPAP ratio for cardiovascular events and mortality in systemic sclerosis with pulmonary hypertension 218
Patient characteristics of HCV-negative mixed cryoglobulinemia (MC) in Italy and Holland 218
EXPERIENCE OF MULTIDISCIPLINARY TEAM FOR COMPLEX HAND FUNCTION PROBLEMS AT THE RHEUMATOLOGY OUTPATIENT CLINIC OF MODENA 214
Tocilizumab for the treatment of patients with rheumatoid arthritis and interstitial lung diseases: a case series 213
Detection of autoimmunity in early primary Epstein-Barr virus infection by Western blot analysis 213
Endothelial Dysfunction in Acute Hepatic Porphyrias 213
ORAL MANIFESTATIONS IN SYSTEMICSCLEROSIS: CLINICAL EVALUATION OF APERSONAL CASE SERIES OF 13 SCLERODERMAPATIENTS 208
Analysis of cryoproteins with a focus on cryofibrinogen: a study on 103 patients 205
IS THERE A DISSOCIATION BETWEEN CLINICAL REMISSION AND ULTRASONOGRAPHIC ASSESSMENT IN RHEUMATOID ARTHRITIS? 205
Ultrasonographic and clinical assessment of peripheral enthesitis and arthritis in an Italian cohort of inflammatory bowel disease patients 202
Efficacy and Drug Survival after Switching from Etanercept to the Biosimilar SB4: A Real-Life Long-Term Study 202
Role of COVID-19 in the progression of scleroderma interstitial lung disease and new onset pulmonary hypertension: a challenging case report. 199
Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern Italy 199
Factors associated of long-term retention rate of Janus kinase inhibitors in a multi-failure rheumatoid arthritis population 198
The New Test for Monitoring Infliximab Therapy: From Laboratory to Clinical Practice 198
Cryoproteinemia: new frontiers for clinicians and the laboratory 193
EFFICACY OF CERTOLIZUMAB PEGOL FOR DISEASE CONTROL OF PATIENTS AFFECTED BY ENTEROPATHIC SPONDYLARTHRITIS FOLLOWED BY THE JOINT GASTRO-RHEUMATOLOGICAL CLINIC 191
Diagnosi di crioproteinemia: preziosa collaborazione tra laboratorio e clinica per la corretta gestione di una patologia rara 191
Cryofibrinogen: A possibile risk factor in systemic sclerosis 189
Does early arthritis clinic organisation improve outcomes? What evidence is there? A systematic review 188
THE PREDICTIVE ROLE OF THE TAPSE/sPAP RATIO FOR CARDIOVASCULAR EVENTS AND MORTALITY IN SYSTEMIC SCLEROSIS COMPLICATED BY PULMONARY HYPERTENSION 186
A CALL FOR A COMPREHENSIVE ROLE DEFINITION OF THE STUDY COORDINATOR IN RHEUMATOLOGICAL CLINICAL STUDIES 183
ACCERTAMENTO DELLA DISABILITÀ NELLE MALATTIE REUMATOLOGICHE (EX L.R. N.4 DEL 19 FEBBRAIO 2008) PROPOSTA DI PROTOCOLLO ORGANIZZATIVO 179
PROBABILITÀ DI SIEROCONVERSIONE DEL TEST QUANTIFERON DURANTE LA TERAPIA BIOTECNOLOGICA: DATI PRELIMINARI DI UNO STUDIO RETROSPETTIVO CONDOTTO PRESSO L’ARTHRITIS CLINIC DELL’AZIENDA OSPEDALIERO-UNIVERSITARIA POLICLINICO DI MODENA 177
CYCLING VS SWAP TNFi AND IL17i IN PSORIATIC ARTHRITIS: RESULTS FROM THE BIRRA RETROSPECTIVE OBSERVATIONAL STUDY 170
PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability 169
Secondary cryofbrinogenemia is related to more severe microangiopathic involvement in systemic sclerosis: results from a retrospective observational study 168
Secondary cryofibrinogenemia is related to more severe microangiopathic involvement in systemic sclerosis: results from a retrospective observational study. 166
CONFRONTO TRA STRATEGIE DI TERAPIA AVANZATA DI 2° E 3° LINEA NELLA ARTRITE PSORIASICA: RISULTATI PRELIMINARI DALLO STUDIO OSSERVAZIONE RETROSPETTIVO BIRRA 165
Analysis of survival rate and persistence predictors of baricitinib in real-world data from a large cohort of rheumatoid arthritis patients 165
JANUS KINASES INHIBITORS IN CLINICAL PRACTICE IN ITALY. RESULTS FROM A SINGLE CENTER EXPERIENCE 165
Cycling versus swapping strategieswith TNF-α inhibitors and IL-17 inhibitors in psoriatic arthritis in clinical practice 161
POS0604 JAKi’S SURVIVAL RATE AND PREDICTORS OF DISCONTINUATION IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS 158
A consensus-based approach on the management of patients with both psoriasis and psoriatic arthritis in the dermatological and rheumatological settings in Italy: The ADOI PSO-Amore Project 157
SAFETY AND EFFICACY OF INTRAVENOUS ILOPROST IN THE TREATMENT AND PREVENTION OF SCLERODERMA-RELATED DIGITAL ULCERS 156
Clinical and ultrasonographic predictors of disease activity after TNF-α inhibitor spacing in patients with psoriatic arthritis 154
Upadacitinib: One More Option in the Treatment of Patients with Rheumatoid Arthritis and Crohn's Disease 152
The management of large vessel vasculitides 150
DIFFERENCES BETWEEN SELECTIVE AND UNSELECTIVE JAKi: RESULTS FROM A MULTICENTRIC, REAL LIFE STUDY CARRIED OUT ON PATIENTS WITH RA 149
Correction: PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability (Modern Pathology, (2020), 33, 7, (1398-1409), 10.1038/s41379-020-0497-0) 149
Impact of the 2023 ACR/EULAR Classification Criteria on START2 Antiphospholipid Registry 144
L’IPERTENSIONE POLMONARE: DALLE NUOVE LINEE GUIDA ALLA PRATICA CLINICA 143
Buerger's disease or thromboangiitis obliterans: description of two cases 135
Influence of safety warnings on the prescribing attitude of JAK 2inhibitors for rheumatoid arthritis in Italy 131
Effectiveness and Predictors of Long-Term Treatment Response to Tofacitinib in Rheumatoid Arthritis Cohort: General Analysis and Focus on High-Cardiovascular-Risk Subgroup— AMulticenter Study 130
Multicenter observational study on the efficacy of selective Janus Kinase-1 inhibitor upatacitinib in rheumatoid arthritis 129
Long-Term Retention Rate of Tofacitinib in Rheumatoid Arthritis: An Italian Multicenter Retrospective Cohort Study 119
Totale 36.593
Salva come PNG Salva come JPEG
Categoria #
all - tutte 104.462
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.462
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.157 0 0 0 109 54 90 59 87 212 72 277 197
2022/20232.719 184 186 171 161 194 293 152 259 313 177 312 317
2023/20245.535 318 249 393 460 512 413 562 550 273 595 618 592
2024/20259.128 570 415 411 676 1.509 1.064 685 627 1.009 559 794 809
2025/202611.424 832 616 1.051 1.492 1.377 693 1.256 594 958 951 894 710
2026/20272.995 475 825 1.105 590 0 0 0 0 0 0 0 0
Totale 37.951